Objectives: The Dynamic Orthotic Cranioplasty (DOC) BandTM is a cranial orthosis used to treat deformational plagiocephaly. The ability of this device to redirect growth and thus, improve craniofacial asymmetry has raised concerns regarding the potential restriction of cranial growth. The purpose of this study was to evaluate the growth of the head during correction of plagiocephaly. Methods: The study sample consisted of 190 children: 81 females (42.6%) and 109 males (57.4%) All patients had been diagnosed with nonsynostotic plagiocephaly, did not have other significant medical conditions, were compliant with DOC protocol, and had complete anthropometric measurements at entrance and exit from treatment. Growth of the head was evaluated using head circumference, maximum cranial width and maximum cranial length. Correction of plagiocephaly was evaluated by documenting the reduction of craniofacial asymmetry of the cranial vault, skull base and face. Paired t tests were used to assess the significance of changes in these anthropometric measurements. Differences were considered significant if p < 0.05. Results: Average entrance age was 6.5 months with a mean treatment time of 4.1 months. Statistical analysis demonstrated highly significant reductions in asymmetry in all three regions (p < 0.001). More importantly, these corrections were achieved with synchronous growth of the skull as demonstrated by highly significant increases (p < 0.001) in head circumference, maximum cranial width and maximum cranial length. Conclusions: These findings document statistically significant increases in cranial growth in association with concomitant reductions of the cranial asymmetries associated with deformational plagiocephaly.

Keywords:
Cranial orthosis, Deformational plagiocephaly, Growth, Development, Anthropometry
1.
American Academy of Pediatrics: AAP Task Force on Infant Positioning and SIDS: Positioning and SIDS. Pediatrics 1992;89:1120–1126.
2.
Havens DH, Zink RL: The ‘Back to Sleep’ campaign. J Pediatr Health Care 1994;8:240–242.
3.
Argenta LC, David LR, Wilson JA, Bell WO: An increase in infant cranial deformity with supine sleeping position. J Craniofac Surg 1996;7:5–11.
4.
Turk AE, McCarthy JG, Thorne CCHM, Wisoff JH: The ‘Back to sleep campaign’ and deformational plagiocephaly: Is there cause for concern? J Craniofac Surg 1996;7:12–18.
5.
Kane A, Mitchell L, Craven K, Marsh J: Observations on a recent increase in plagiocephaly without synostosis. Pediatrics 1996;97:877–885.
6.
Clarren SK, Smith DW, Hanson JW: Helmet treatment for plagiocephaly and congenital muscular torticollis. J Pediatr 1979;94:43–46.
7.
Nichter LS, Persing JA, Horowitz JH, Morgan RF, Nichter MA, Edgerton MT: External Cranioplasty: Historical perspectives. Plastic Reconstr Surg 1986;77:325–332.
8.
Pattisapu JV, Walker NL, Myers GG, Cheever J: Use of helmets for positional molding. Concepts Pediatr Neurosurg 1989;9:178–184.
9.
Pollack IF, Losken HW, Fasick P: Diagnosis and management of posterior plagiocephaly. Pediatrics 1997;99:180–185.
10.
Pomatto JK: Cranial Technologies Inc, US Patent No 5,094,229, March 10, 1992; developed in conjunction with Stephen P. Beals, Southwest Craniofacial Center, and Kim H. Manwaring, Division of Neurosurgery, Phoenix Children’s Hospital.
11.
Ripley CE, Pomatto JK, Beals SP, Joganic EF, Manwaring KH, Moss SD: Treatment of positional plagiocephaly with Dynamic Orthotic Cranioplasty. J Craniofac Surg 1994;5:150–159.
12.
Littlefield TR, Beals SP, Manwaring KH, Pomatto JK, Joganic EF, Golden KA, Ripley CE: Treatment of craniofacial asymmetry with Dynamic Orthotic Cranioplasty. J Craniofac Surg 1998;9:11–17.
13.
Kelly KM, Littlefield TR, Pomatto JK, Ripley CE, Beals SP, Joganic EF: Importance of early recognition and treatment of deformational plagiocephaly with orthotic cranioplasty. Cleft Palate Craniofac J 1999;36:127–130.
14.
Craniosynostosis and Skull Molding Symposium. Scottsdale, February 1997.
15.
International Society of Craniofacial Surgery, VII International Congress. Santa Fe, September 1997.
16.
Farkas LG: Anthropometry of the Head and Face in Medicine. New York, Elsevier, 1981.
17.
Hajnis K: Kopf-, Ohrmuschel- und Handwachs- tum (Verwendung bei den Operationen der angeborenen Missbildungen und Unfallsfolgen). Acta Univ Carol [Biol] Praha 1972; 1974;2–4:77.
18.
Kolar JC, Salter EM: Craniofacial Anthropometry. Practical Measurement of the Head and Face for Clinical, Surgical and Research Use. Springfield, Thomas, 1997.
19.
SAS Institute Inc: SAS/STAT User’s Guide, Version 6. Cary, SAS Institute Inc, 1989 vol 2, pp 846.
20.
Dekaban AS: Tables of cranial and orbital measurements, cranial volume, and derived indexes in males and females from 7 days to 20 years of age. Ann Neurol 1977;2:485–491.
21.
Hellbusch JL, Hellbusch LC, Bruneteau RJ: Active counterpositioning treatment of deformational plagiocephaly. Neb Med J 1995;80:344–349.
22.
Moss SD: Nonsurgical, nonorthotic treatment of occipital plagiocephaly: What is the natural history of the misshapen neonatal head? J Neurosurg 1997;87:667–670.
23.
Mulliken JB, Vander Woude DL, Hansen M, LaBrie RA, Scott RM: Analysis of posterior plagiocephaly: Deformational versus synostotic. Plastic Reconstr Surg 1999;103:371–380.
24.
Consensus Statement Issued at the Craniosynostosis and Skull Molding Symposium. Scottsdale, February 1997.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.